|
US2014351964A1
|
|
Transgenic mouse model for developing enzyme replacement therapy for iduronate-2-sulfatase deficiency syndrome
|
|
KR20140046781A
|
|
Composition for preventing or treating of choroidal neovascularization including complement factor h
|
|
KR101158673B1
|
|
Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
|
|
KR20140048105A
|
|
Pharmaceutical composition for the prevention or treatment of mucolipidosis ii, comprising a lysosomal enzyme as an active ingredient
|
|
KR20120116421A
|
|
Use of inhalable powder formulation comprising growth hormone for preventing or treating nmda receptor hypofunction-related diseases
|
